Clinical Trials Directory

Trials / Unknown

UnknownNCT05525260

Limonene for Pulmonary Nodule Chemoprevention

A Randomized Phase II Trial of Limonene for Pulmonary Nodule Chemoprevention

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The prevention and treatment of lung nodules involves many fields in preventive medicine and clinical medicine. A nodule is a growth or lump that may be malignant (cancer) or benign (not cancer). This study is aim to investigate the chemopreventive effect of limonene in inhibiting the occurrence/progression of ground glass pulmonary nodules. It is expected that limonene can be used as a safe and effective chemopreventive agent for preventing the development/progress of pulmonary nodules as well as expanding the indications of limonene.

Detailed description

Early prevention, early detection and early treatment of lung cancer can help reduce the incidence and improve the survival rate.Chemoprevention is known to have an important role in high-risk people because it has the potential to prevent or reverse the progression of lung cancer.Lung nodules are good targets for testing the efficacy of chemopreventive agents.So far,none of the chemopreventive agents have been shown to be effective. Limonene is widely found in the essential oils of traditional Chinese medicine tangerine peel, green peel and other plants. Its taste is sour, sweet and pungent. It has an aromatic odor effect. Limonene Capsule, a Chinese patent medicine, has been on the market, which is suitable for the treatment of cholecystitis, cholangitis, cholelithiasis, and postoperative biliary syndrome.Preliminary studies of the research group suggest that it has a potential anti-cancer effect. This randomized, double-blind, controlled trial studied limonene compared with placebo in treating high-risk patients with pure ground glass pulmonary nodules,so as to expand indications.

Conditions

Interventions

TypeNameDescription
DRUGLimonene capsuleCitrus foods rich in D-limonene were forbiden 2 days before taking the drug (washout period), which was maintained after taking the drug.Limonene capsules group and placebo group were used for treatment. The random number is generated by the central randomization system. All the recruiters were divided into placebo control group and limonene capsule administration group. The numbers will be assigned according to random numbers. In this study, qualified subjects were randomly assigned to the treatment group and the placebo control group at a ratio of 1:1. The drug was administered for 12 weeks, 3 times a day, 5 capsules each time.
DRUGLimonene capsules(Placebo)Limonene capsules(Placebo)

Timeline

Start date
2023-02-01
Primary completion
2024-02-01
Completion
2025-12-01
First posted
2022-09-01
Last updated
2023-02-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05525260. Inclusion in this directory is not an endorsement.